Pharmaceutical Packaging Equipment Market Size, Share, Trends, Growth, and Forecasts for 2025 - 2032

Pharmaceutical Packaging Equipment Market by Automation (Automatic, Semi-automatic, Manual), Application (Tablets, Powders, Cream, Syrup, Aerosol), Machine Type (Bottling Line, Cartoning, Form-fill-seal [FFS], Blister Packaging, Capping & Closing, Filling & Sealing, Labelling, Decorating & Coding, Palletizing, Wrapping & Bundling), and Regional Analysis for 2025 - 2032

ID: PMRREP3037

Format: PPT*, PDF, EXCEL

Last Updated: 1 Sep 2025

Industry: Healthcare

Number of Pages: 199

Persistence Market Research Report, Market Growth and Regional Outlook

Pharmaceutical Packaging Equipment Market Size and Trends Analysis

The global pharmaceutical packaging equipment market size is likely to be valued at US$ 9.7 Bn in 2025 and estimated at US$ 16.1 Bn by 2032 growing at CAGR of 7.5% during forecast period 2025-2032.

Pharmaceutical packaging equipment is a critical segment of the pharmaceutical industry, driven by demand for pharma machinery, blister packaging, and cartoning machines to ensure safe, efficient, and compliant packaging solutions. The market growth benefits from expanding pharmaceutical production, growth in generics, and the rise of personalized medicine, pushing manufacturers to invest in high-speed, flexible, and sustainable packaging solutions.

Key Industry Highlights:

  • Dominant Automation Type: Automatic equipment holds a 50% market share in 2025, driven by high-speed pharmaceutical cartoning equipment.
  • Leading Packaging Type: Blister Packaging supported by pharma blister packaging machinery suppliers. It supports sterile packaging equipment for tablets.
  • Prominent Application: Tablets application driven by sterile packaging equipment. It relies on blister packaging and pharmaceutical labeling machines for high-volume production.
  • Fast-growing Application: Aerosol application is fueled by aseptic packaging equipment. It supports healthcare packaging machinery for respiratory drugs.
  • Leading Region: North America holds a 40% market share, with the U.S. leading in track and trace technology in pharma.
  • Rapid Growing: Asia Pacific accounts 25%, driven by healthcare packaging machinery.
  • Regulatory Compliance: Stringent regulations increased serialization in pharma packaging adoption by 25%.

Global Market Attribute

Key Insights

Pharmaceutical Packaging Equipment Market Size (2025E)

US$ 9.7 Bn

Market Value Forecast (2032F)

US$ 16.1 Bn

Projected Growth (CAGR 2025 to 2032)

7.5%

Historical Market Growth (CAGR 2019 to 2024)

6.8%

Market Dynamics

Driver - Rising Pharmaceutical Production and Stringent Regulatory Requirements

The pharmaceutical packaging equipment market is propelled by the rising global pharmaceutical production and stringent regulatory requirements, driving demand for pharma machinery, blister packaging, and cartoning machines. In 2025, global pharmaceutical sales reached US$ 1.48 Tn, with a 5.8% annual growth rate, boosting demand for high-speed pharmaceutical cartoning equipment and sterile packaging equipment by 20%.

Regulatory bodies such as the FDA and EMA mandate serialization in pharma packaging and track and trace technology in pharma, with 90% of U.S. pharmaceutical products requiring serialization in 2025, increasing adoption of pharmaceutical labeling machines by 25%. The rise in chronic diseases, affecting 60% of adults globally, drives liquid filling systems and aseptic packaging equipment for syrup and aerosol applications, with 15% growth in 2025. Marchesini Group reported 12% revenue growth in 2025 from pharma packaging technology, driven by medical packaging systems. The global push for cold chain packaging solutions, with US$ 20 Bn in investments by 2025, supports smart pharma packaging for biologics, positioning the market for sustained growth across tablets and powders applications.

Restraint - High Initial Investment and Maintenance Costs

The pharmaceutical packaging equipment market faces challenges due to high initial investment and maintenance costs for healthcare packaging machinery and aseptic packaging equipment. Installing high-speed pharmaceutical cartoning equipment and liquid filling systems costs between US$ 500,000 and US$ 2 Mn per unit, limiting adoption by small and medium-sized enterprises (SMEs). Maintenance costs, requiring 15% of equipment value annually, impact pharma blister packaging machinery suppliers and secondary packaging solutions, increasing operational expenses by 20%.

Regulatory compliance for serialization in pharma packaging and track and trace technology in pharma adds 10% to setup costs, particularly affecting pharmaceutical labeling machines. These constraints slow market expansion in emerging regions, where 30% of manufacturers face budget limitations, impacting manual and semi-automatic equipment adoption.

Opportunity - Advancements in Sustainable and Smart Packaging Solutions

Advancements in sustainable pharmaceutical packaging solutions and smart pharma packaging present significant opportunities for the pharmaceutical packaging equipment market, driving demand for medical packaging systems and cold chain packaging solutions. In 2025, the global sustainable packaging market reached US$ 280 Bn, with a 6.5% CAGR, boosting blister packaging and cartoning machines with eco-friendly materials by 15%.

Smart pharma packaging, integrating IoT and RFID for track and trace technology in pharma, saw 20% adoption in 2025, enhancing pharmaceutical labeling machines for real-time monitoring. Emerging markets, with US$ 50 Bn in pharmaceutical infrastructure investments, offer potential for aseptic packaging equipment and secondary packaging solutions, particularly for aerosol and cream applications. Uhlmann Group reported 10% growth in 2025 from sustainable pharmaceutical packaging solutions, positioning the market for expansion in tablets and syrup segments.

Category-wise Analysis

Automation Insights

Automatic equipment holds a 50% market share in 2025, driven by high-speed pharmaceutical cartoning equipment. It supports pharma packaging technology for high-volume production. Equipped with advanced features such as robotics, real-time monitoring, and serialization integration, these machines support the pharmaceutical industry's growing need for track and trace technology and tamper-proof solutions. Additionally, automatic equipment contributes to labor cost reduction and improved operational efficiency, making it the preferred choice for large pharmaceutical manufacturers.

Semi-automatic equipment fueled by healthcare packaging machinery for SMEs. It offers flexibility for sterile packaging equipment in tablets and powders applications. These machines allow operators to maintain oversight of critical steps while still benefiting from automation in repetitive tasks, striking a balance between efficiency and affordability. With increasing adoption among emerging market manufacturers and niche pharmaceutical players, semi-automatic equipment remains an attractive choice for businesses aiming to achieve compliance and productivity without significant capital expenditure.

Application Insights

Tablets application commands a 35% market share in 2025, driven by sterile packaging equipment. it relies on blister packaging and pharmaceutical labeling machines for high-volume production. pharmaceutical labeling machines with track and trace capabilities play a crucial role in enabling serialization, ensuring compliance with global regulations such as DSCSA and EU FMD. The adoption of digital printing and smart labels further enhances patient safety and authenticity. The growing demand for generic drugs, coupled with cost-effective, high-speed production systems, continues to fuel the growth of this segment.

Aerosol application is fueled by aseptic packaging equipment. It supports healthcare packaging machinery for respiratory drugs. The growing prevalence of chronic respiratory diseases, combined with innovations in inhalation devices and the expansion of biologics requiring specialized aerosol packaging, positions this segment for strong growth. Manufacturers are increasingly focusing on sustainable propellants and eco-friendly aerosol systems to align with environmental guidelines, adding another layer of innovation to this market.

Machine Type Insights

Blister Packaging holds a 30% market share in 2025, driven by pharma blister packaging machinery suppliers. It supports sterile packaging equipment for tablets. Blister packs offer tamper-proof and moisture-resistant barriers, which are essential for patient safety and regulatory compliance, further strengthening their adoption in both prescription and OTC drug markets.

Labelling is fueled by pharmaceutical labeling machines and track and trace technology in pharma. it supports serialization in pharma packaging. These technologies not only enhance brand protection and patient safety but also facilitate real-time monitoring and digital authentication of products throughout the distribution network. The increasing push toward smart labeling solutions and digital printing for customization further accelerates this segment’s growth.

Regional Insights

North America Pharmaceutical Packaging Equipment Market Trends

North America holds a 40% global market share in 2025, valued at US$ 3.88 Bn, with the U.S. leading due to advanced pharmaceutical infrastructure. The U.S. market, driven by track and trace technology in pharma and serialization in pharma packaging. In 2025, 50% of U.S. pharmaceutical companies adopted pharmaceutical labeling machines, supported by FDA’s Drug Supply Chain Security Act (DSCSA), increasing smart pharma packaging adoption by 25%.

The rise in biologics, with US$ 150 Bn in sales, boosts cold chain packaging solutions and aseptic packaging equipment. Körber AG holds a 15% regional share, leveraging pharma packaging technology for tablets and syrup. Investments in healthcare packaging machinery, reaching US$ 10 Bn by 2025, drive sustainable pharmaceutical packaging solutions in blister packaging.

Europe Pharmaceutical Packaging Equipment Market Trends

Europe accounts for a 30% global share, valued at US$ 2.91 Bn in 2025, led by Germany, the UK, and France, driven by stringent regulations and pharmaceutical innovation. Germany’s market generating US$ 1.16 Bn, propelled by pharma blister packaging machinery suppliers and sterile packaging equipment.

The pharmaceutical sector, contributing €300 Bn to the economy, saw 40% of manufacturers adopt high-speed pharmaceutical cartoning equipment in 2025, driven by EU GMP regulations. The UK market, is driven by pharmaceutical labeling machines, with 35% adoption for serialization in pharma packaging. France’s market grows at 8%, fueled by cold chain packaging solutions, with €200 Mn in biologics investments. Uhlmann Group leads with secondary packaging solutions, capturing 12% of the market.

Asia Pacific Pharmaceutical Packaging Equipment Market Trends

Asia Pacific is the fastest-growing region, with a CAGR of 8.2%, valued at US$ 2.91 Bn in 2025, led by China, Japan, and India, driven by pharmaceutical production and generics growth. China holds a 50% regional share, generating US$ 1.46 Bn in 2025, fueled by US$ 50 Bn in pharma investments, boosting healthcare packaging machinery and liquid filling systems. In 2025, 45% of Chinese manufacturers adopted aseptic packaging equipment.

India’s pharmaceutical packaging market is driven by 30% growth in generics, with 40% adoption of pharma blister packaging machinery suppliers. Japan’s market sees 10% growth, with 35% adoption of pharmaceutical labeling machines for biologics. ACG Worldwide captures 10% of the regional market with smart pharma packaging.

Competitive Landscape

The global pharmaceutical packaging equipment market is highly competitive, with Marchesini Group, Körber AG, I.M.A. Industria Macchine Automatiche S.p.A., Uhlmann Group, Accutek Packaging Equipment Companies, Bausch + Ströbel, Coesia, Vanguard Pharmaceuticals Equipment, MULTIVAC Group, OPTIMA Packaging Group, ACG Worldwide, and Brevetti CEA S.p.A. focusing on pharma machinery, blister packaging, and cartoning machines.

Companies leverage serialization in pharma packaging and track and trace technology in pharma to gain market share. Strategic R&D investments in sustainable pharmaceutical packaging solutions and partnerships drive healthcare packaging machinery, addressing smart pharma packaging needs.

Industry Developments:

  • In August 2024, I.M.A. Industria Macchine Automatiche S.p.A. acquired Sarong's packaging machinery and e-packaging materials divisions, a move aimed at enhancing its product offerings in the packaging sector. This acquisition will expand the company’s capabilities in providing innovative and sustainable packaging solutions, particularly in the food and pharmaceutical industries. The integration of Sarong's expertise allows I.M.A. Industria Macchine Automatiche S.p. A. to strengthen its market position and respond effectively to evolving customer demands.
  • In December 2023, MULTIVAC Group inaugurated its latest production facility in India. With an investment of approximately USD 9 million, the state-of-the-art Sales and Production complex boasts a 10,000-square-meter floor area and is set to commence operations in early 2024. The facility will initially employ about 60 individuals, aiming to enhance customer service in India, Sri Lanka, and Bangladesh by strategically positioning itself regionally and reducing delivery times.

Companies Covered in Pharmaceutical Packaging Equipment Market

  • Marchesini Group
  • Körber AG
  • I.M.A. Industria Macchine Automatiche S.p.A.
  • Uhlmann Group
  • Accutek Packaging Equipment Companies
  • Coesia
  • Vanguard Pharmaceuticals Equipment
  • MULTIVAC Group
  • OPTIMA Packaging Group
  • ACG Worldwide
  • Brevetti CEA S.p.A.
  • Others

Frequently Asked Questions

The pharmaceutical packaging equipment market is projected to reach US$ 9.7 Bn in 2025, driven by pharma machinery and blister packaging.

Global pharmaceutical sales of US$ 1.48 Tn in 2025 and stringent regulations fuel serialization in pharma packaging.

The market grows at a CAGR of 7.5% from 2025 to 2032, reaching US$ 16.1 Bn by 2032.

Advancements in sustainable pharmaceutical packaging solutions and smart pharma packaging, with 20% IoT adoption, offer growth potential.

Key players include Marchesini Group, Körber AG, Uhlmann Group, I.M.A., and ACG Worldwide.

Global Pharmaceutical Packaging Equipment Market Report Scope

Report Attribute

Details

Historical Data/Actuals

2019 - 2024

Forecast Period

2025 - 2032

Market Analysis Units

Value: US$ Bn, Volume: As Applicable

Geographical Coverage

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Segmental Coverage

  • Automation
  • Application
  • Machine Type
  • Region

Competitive Analysis

  • Marchesini Group
  • Körber AG
  • I.M.A. Industria Macchine Automatiche S.p.A.
  • Uhlmann Group
  • Accutek Packaging Equipment Companies
  • Coesia
  • Vanguard Pharmaceuticals Equipment
  • MULTIVAC Group
  • OPTIMA Packaging Group
  • ACG Worldwide
  • Brevetti CEA S.p.A.
  • Others

Report Highlights

  • Market Forecast and Trends
  • Competitive Intelligence and Share Analysis
  • Growth Factors and Challenges
  • Strategic Growth Initiatives
  • Pricing Analysis
  • Future Opportunities and Revenue Pockets

Customization and Pricing

Available upon request

Market Segmentation

By Automation

  • Automatic
  • Semi-automatic
  • Manual

By Application

  • Tablets
  • Powders
  • Cream
  • Syrup
  • Aerosol

By Machine Type

  • Bottling Line
  • Cartoning
  • Form-fill-seal (FFS)
  • Blister Packaging
  • Capping & Closing
  • Filling & Sealing
  • Labelling
  • Decorating & Coding
  • Palletizing
  • Wrapping & Bundling

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

For more information on this report and its delivery timelines please get in touch with our sales team.

About Author

Anu Jamwal

Anu Jamwal

Senior Consultant

Anu is a Senior Consultant with over a decade of experience and has developed deep expertise in clinical diagnostics, biotechnology, animal health, healthcare IT, and pharmaceuticals, including pipeline assessment. She has authored comprehensive reports providing both global and regional competitive intelligence. She has also successfully led consulting assignments focused on business strategies, product launches, and medical census studies.

Read More →

Thank you for taking time to visit our website, click like if you found the information on this page useful?

This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate